DST Result of 1.1 µg/dL: Normal and Excludes Cushing's Syndrome
A cortisol level of 1.1 µg/dL after a 1-mg overnight dexamethasone suppression test is normal and effectively rules out Cushing's syndrome. This value falls well below the diagnostic threshold of 1.8 µg/dL (50 nmol/L) recommended by current guidelines. 1, 2
Interpretation Framework
Normal Suppression Criteria
The 2021 Endocrine Society consensus guideline establishes that serum cortisol < 1.8 µg/dL (50 nmol/L) at 8 AM following 1 mg dexamethasone given at 11 PM represents normal suppression and excludes dysregulated cortisol production. 1
Your result of 1.1 µg/dL is 39% below this cutoff, providing a clear negative result with high confidence. 1
The 2008 Endocrine Society guideline confirms that a negative DST result "strongly predicts CS absence." 2
Diagnostic Accuracy at This Level
At the 1.8 µg/dL threshold, the overnight DST demonstrates sensitivity above 90% for detecting Cushing's syndrome. 1
Research demonstrates that in healthy controls, only 2.6% (5 of 190 subjects) had cortisol levels > 2.0 µg/dL after dexamethasone suppression, confirming that values around 1.1 µg/dL are unequivocally normal. 3
A 1984 study showed that cortisol falling below 2.2 µg/dL (60 nmol/L) occurred in at least 97% of subjects without Cushing's syndrome, further validating your result as normal. 4
Important Caveats to Consider
Ensure Test Validity
Before accepting this result as definitive, verify that dexamethasone was absorbed appropriately:
Concurrent measurement of serum dexamethasone levels ≥ 0.1 µg/dL (or ≥ 3.48-4.5 nmol/L depending on assay) confirms adequate drug exposure and validates the test. 5, 6, 7
If dexamethasone was not measured, consider whether the patient:
- Actually took the medication as prescribed (11% of tests show inadequate dexamethasone levels, with 17-25% of those due to non-compliance). 8
- Was taking CYP3A4 inducers (phenobarbital, carbamazepine, phenytoin, rifampin, St. John's wort) that accelerate dexamethasone metabolism and could cause false-negative results. 1, 2
- Had gastrointestinal disorders (celiac disease, chronic diarrhea, malabsorption) that impair dexamethasone absorption. 1
Cyclic Cushing's Syndrome Exception
If clinical suspicion remains high despite this normal result, cyclic Cushing's syndrome must be considered—patients may have normal cortisol secretion for weeks to months interspersed with hypercortisolemic episodes. 1, 9
In this scenario, repeat testing with multiple 24-hour urinary free cortisol or late-night salivary cortisol collections over several weeks is recommended to capture episodic hypercortisolism. 1, 9
Re-evaluation in 6 months is appropriate if symptoms progress or new features develop. 9
Mild Autonomous Cortisol Secretion (MACS)
For patients with adrenal incidentalomas, the DST distinguishes normal suppression (< 1.8 µg/dL) from MACS (1.8-5.0 µg/dL) and overt autonomous secretion (> 5.0 µg/dL). 1
Your result of 1.1 µg/dL excludes both MACS and overt Cushing's syndrome in the context of an adrenal incidentaloma. 1
Clinical Bottom Line
No further biochemical workup for Cushing's syndrome is needed with a post-DST cortisol of 1.1 µg/dL, assuming:
- The patient took dexamethasone correctly (ideally confirmed by serum dexamethasone measurement). 5, 6
- No CYP3A4-inducing medications or malabsorption disorders are present. 1, 2
- Clinical features do not strongly suggest cyclic Cushing's syndrome. 1, 9
If any of these conditions are uncertain, measure serum dexamethasone retrospectively if available, or repeat the DST with concurrent dexamethasone measurement to validate the result. 5, 6 Otherwise, this result provides robust evidence against Cushing's syndrome. 1, 2